These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21612548)

  • 1. An interview with Ken Valenzano, Ph.D. Interview by Vicki Glaser.
    Valenzano KJ
    Assay Drug Dev Technol; 2011 Jun; 9(3):191-7. PubMed ID: 21612548
    [No Abstract]   [Full Text] [Related]  

  • 2. An interview with Steven M. Watkins, Ph.D., president and chief scientific officer, Lipomics Technologies, Inc. Interview by Vicki Glaser.
    Watkins SM
    Assay Drug Dev Technol; 2004 Aug; 2(4):339-43. PubMed ID: 15357914
    [No Abstract]   [Full Text] [Related]  

  • 3. An interview with Richard M. Eglen, Ph.D.
    Eglen RM
    Assay Drug Dev Technol; 2006 Oct; 4(5):503-9. PubMed ID: 17115921
    [No Abstract]   [Full Text] [Related]  

  • 4. An interview with Kenneth C. Lewis, Ph.D., CEO, and Joseph D. Simpkins, Vice President, Software, OpAns (Optimized Analytical Solutions), Durham, NC. Interview by Vicki Glaser.
    Lewis KC; Simpkins JD
    Assay Drug Dev Technol; 2007 Dec; 5(6):695-702. PubMed ID: 18181688
    [No Abstract]   [Full Text] [Related]  

  • 5. Interview with John W. Kozarich, PhD. Interview by Vicki Glaser.
    Kozarich JW
    Assay Drug Dev Technol; 2013 Jun; 11(5):283-8. PubMed ID: 23772549
    [No Abstract]   [Full Text] [Related]  

  • 6. An interview with Thomas Levelli. Interview by Vicki Glaser.
    Levelli T
    Assay Drug Dev Technol; 2005 Feb; 3(1):1-6. PubMed ID: 15798390
    [No Abstract]   [Full Text] [Related]  

  • 7. An interview with D. Lansing Taylor, Ph.D., Chief Executive Officer, Cellomics, Inc. Interview by Vicki Glaser.
    Taylor DL
    Assay Drug Dev Technol; 2003 Aug; 1(4):501-5. PubMed ID: 15090246
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: biopharmaceutical technologies.
    Jungbauer A
    Biotechnol J; 2007 Jun; 2(6):647. PubMed ID: 17570696
    [No Abstract]   [Full Text] [Related]  

  • 9. Literature search and review.
    Auld D; Lea W; Davis MI; Simeonov A
    Assay Drug Dev Technol; 2011 Jun; 9(3):198-212. PubMed ID: 21612549
    [No Abstract]   [Full Text] [Related]  

  • 10. Interview with Marc Ferrer, Ph.D.. Interview by Vicki Glaser.
    Ferrer M
    Assay Drug Dev Technol; 2010 Jun; 8(3):263-7. PubMed ID: 20589994
    [No Abstract]   [Full Text] [Related]  

  • 11. Venturing into drug discovery.
    Steinmetz M
    Nat Biotechnol; 1998 May; 16 Suppl():17. PubMed ID: 9591255
    [No Abstract]   [Full Text] [Related]  

  • 12. Being a modern pharmaceutical company: new paradigms for the pharmaceutical industry.
    Hassan F
    Clin Pharmacol Ther; 2001 May; 69(5):281-5. PubMed ID: 11371995
    [No Abstract]   [Full Text] [Related]  

  • 13. Interview with Thomas P. Monath, M.D. Interview by Vicki Glaser.
    Monath TP
    Vector Borne Zoonotic Dis; 2005; 5(3):300-4. PubMed ID: 16187902
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 15. The power of genomics to transform the biotechnology industry.
    Haseltine WA
    Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259
    [No Abstract]   [Full Text] [Related]  

  • 16. The onset of a revolution in drug discovery.
    Chatni MR
    Trends Biotechnol; 2007 Apr; 25(4):142-4. PubMed ID: 17306391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bristol-Myers Squibb locks into novel autoimmune strategy.
    Garber K
    Nat Biotechnol; 2016 Jun; 34(6):577-9. PubMed ID: 27281396
    [No Abstract]   [Full Text] [Related]  

  • 18. New drug development in the United States from 1963 to 1990.
    DiMasi JA; Bryant NR; Lasagna L
    Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):471-86. PubMed ID: 1934860
    [No Abstract]   [Full Text] [Related]  

  • 19. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
    Napper AD
    IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
    [No Abstract]   [Full Text] [Related]  

  • 20. Development trends for therapeutic antibody fragments.
    Nelson AL; Reichert JM
    Nat Biotechnol; 2009 Apr; 27(4):331-7. PubMed ID: 19352366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.